Dow Jones Index

Dow Jones Index Injected With EPO And Growth Hormones

Dow Jones Index Injected With EPO And Growth Hormones Again by Wim Grommen
It is becoming more and more meaningless to compare the performance of the Dow 30 from one period to another with the continuing replacement of constituent companies that have under-performing and lower priced stocks (losers out) with companies that have higher priced stocks with greater future prospects for price appreciation (winners in).

We explain below exactly what this reconfiguring (and the further change in the Dow Divisor) encompasses and exactly how it will affect the performance of the index. Read on, its significance is absolutely dramatic . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required


Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 11/30/2019 or after next 25 13 subscribers take advantage whichever comes first – please do not share this discount with others

 

0